Calithera Biosciences Inc (CALA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO, CA 94080

Calithera Biosciences, Inc. provides pharmaceutical products. The Company is focused on discovering and developing novel small molecule drugs directed against tumor metaboli® and tumor immunology targets for the treatment of cancer.

Data as of 2020-05-30
Market Cap409.984 Million Shares Outstanding70.444 Million Avg 30-day Volume968.557 Thousand
P/E Ratio Dividend Yield EPS-1.72
Price/Sales Price cash flow ratio14.7 Price free cash flow ratio-4.8
Book Value1.81 Price to Tangible Book3.21 Alpha0.0
Short Interest Ratio % Short Interest to Float R-squared0.144448
BETA2.30082 52-week High/Low8.18 / 2.45 Stddev0.258364
View SEC Filings from CALA instead.

View recent insider trading info

Funds Holding CALA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CALA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

2.3 Million total shares from 4 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WADDILL WILLIAM D.

  • Director
0 2020-05-28 0

DRACHMAN JONATHAN G

  • Director
0 2020-05-28 0

PAKIANATHAN DEEPIKA

  • Director
0 2020-05-21 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
480,432 2020-05-21 4

MOLINEAUX SUSAN

  • Director
41,206 2020-04-28 2

WONG STEPHANIE SR. VP, FINANCE & SECRETARY

  • Officer
37,301 2020-04-15 3

ORFORD KEITH CHIEF MEDICAL OFFICER

  • Officer
8,541 2020-02-20 4

GEORGE JEAN

  • Director
5,127 2020-01-22 0

MOLINEAUX CHRISTOPHER SR. VP, DEVELOPMENT

  • Officer
0 2020-01-17 2

SJOGREN ERIC SR. VP, DRUG DISCOVERY

  • Officer
0 2020-01-17 2

HECHT CURTIS SVP, CHIEF BUSINESS OFFICER

  • Officer
0 2020-01-17 1

PARLATI FRANCESCO VP, RESEARCH

  • Officer
0 2020-01-17 2

RAY SUMITA SEE REMARKS

  • Officer
0 2020-01-17 1

ADAGE CAPITAL PARTNERS GP, L.L.C.

ADAGE CAPITAL PARTNERS, L.P.

ADAGE CAPITAL ADVISORS, L.L.C.

ATCHINSON ROBERT

GROSS PHILLIP

  • 10% Owner
7,828,550 2019-11-20 0

WOLFF HENRY WARD

  • Director
0 2019-06-28 0

AGARWAL SUNIL

  • Director
0 2019-06-13 0

JONES SUZY

  • Director
0 2019-05-30 0

WISE BLAKE

  • Director
0 2019-05-30 0

MORGENTHALER VENTURE PARTNERS IX LP

  • 10% Owner
No longer subject to file 2017-06-01 0

BENNETT MARK K SR. VP, RESEARCH

  • Officer
0 2016-11-29 0

DELPHI MANAGEMENT PARTNERS VIII, L.L.C.

BOCHNOWSKI JAMES J

DELPHI BIOINVESTMENTS VIII LP

DELPHI VENTURES VIII LP

DOUGLASS DAVID L

PAKIANATHAN DEEPIKA

ROEDER DOUGLAS A

  • Director
  • 10% Owner
11,346,946 2016-03-23 0

ADVANCED TECHNOLOGY VENTURES VIII LP

ATV ASSOCIATES VIII, L.L.C.

  • 10% Owner
0 2015-06-24 0

CHRISTOFFERSEN RALPH E

  • Director
  • 10% Owner
2,161,915 2014-10-07 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

BVF PARTNERS L P/IL - > 10% Owner

BIOTECHNOLOGY VALUE FUND L P SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2020-05-21 S 1,064,332 $6.00 d 2,766,561 480,432.00 direct

BVF PARTNERS L P/IL - > 10% Owner

BIOTECHNOLOGY VALUE FUND L P SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2020-05-21 S 1,027,016 $6.00 d 3,712,340 480,432.00 direct

BVF PARTNERS L P/IL - > 10% Owner

BIOTECHNOLOGY VALUE FUND L P SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE FUND II LP SEE EXPLANATION OF RESPONSES

BIOTECHNOLOGY VALUE TRADING FUND OS LP SEE EXPLANATION OF RESPONSES

BVF PARTNERS OS LTD. SEE EXPLANATION OF RESPONSES

BVF INC/IL - > 10% Owner

LAMPERT MARK N - > 10% Owner

2020-05-21 S 192,250 $6.00 d 480,432 480,432.00 direct

WONG STEPHANIE - Officer SR. VP, FINANCE & SECRETARY

2020-04-15 S 5,000 $8.00 d 30,082 37,301.00 direct yes

Elevate your investments